1.     Datafrom MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous CellCarcinoma 2023. https://doi.org/10.1158/1078-0432.C.6517990.V1.

2.     Kanwal N, Al Samarrai O, Al-Zaidi HMH, Mirzaei A, Heidari M.Comprehensive analysis of microRNA (miRNA) in cancer cells. Cell Mol Biomed Reports 2023;3:89–97.https://doi.org/10.55705/CMBR.2022.364591.1070.

3.     Dong Y,Wen W, Yuan T, Liu L, Li X. Novel Prognostic Biomarkers for Cervical SquamousCell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis ofCompeting Endogenous RNA (ceRNA) Network. Dis Markers 2023;2023:1–12.https://doi.org/10.1155/2023/1766080.

4.     Zhang G,Zhang R, Bai P, Li S, Zuo J, Zhang Y, et al. Down-regulated expression ofmiR-99a is associated with lymph node metastasis and predicts poor outcome instage IB cervical squamous cell carcinoma: a case-control study. Ann Transl Med2022;10:663–663. https://doi.org/10.21037/ATM-22-2483.

5.     Jia S,Zhang M, Li Y, Zhang L, Dai W. MAGE-A11 Expression Predicts Patient Prognosisin Head and Neck Squamous Cell Carcinoma. Cancer Manag Res 2020;12:1427.https://doi.org/10.2147/CMAR.S237867.

6.     ThomaidouAC, Batsaki P, Adamaki M, Goulielmaki M, Baxevanis CN, Zoumpourlis V, et al.Promising Biomarkers in Head and Neck Cancer: The Most Clinically ImportantmiRNAs. IntJ Mol Sci 2022, Vol 23, Page 8257 2022;23:8257.https://doi.org/10.3390/IJMS23158257.

7.     GintoniI, Vassiliou S, Chrousos GP, Yapijakis C. Review of Disease-Specific microRNAsby Strategically Bridging Genetics and Epigenetics in Oral Squamous CellCarcinoma. Genes (Basel) 2023;14. https://doi.org/10.3390/GENES14081578.